1 January 2025 in Biomolecular and Health Science Journal
Introduction: Hepcidin is an acute-phase reactant involved in regulating systemic iron levels. In acute infections such as sepsis, hepcidin levels rise. However, few studies have explored the role of hepcidin in assessing sepsis outcomes in children, and its relationship to mortality remains unclear. Most existing research suggests that high hepcidin levels may reduce the risk of sepsis-related death in children. This study aimed to investigate whether high hepcidin levels serve as a protective factor for clinical outcomes in pediatric sepsis. Methods: This observational analytic cohort study assessed high hepcidin levels in pediatric sepsis patients in the Pediatric Intensive Care Unit from October 2021 to June 2022, using consecutive sampling. Data were analyzed with Chi-square tests and logistic regression, with statistical significance set at P < 0.05. Results: This study involved 59 pediatric sepsis with 57.6% with age >12 years old, 61% males, 54.2% well nourished, 66.1% source infection from the respiratory tract, 54.2% septic shock, 18.6% bacteremia, 66.1% without comorbid and 54.2% outcome alive. Analysis receiver operating characteristic curve analysis showed an area under the curve (AUC) of 40.0%, with a cutoff of 1312 pg/ml to differentiate high and low hepcidin levels. Bivariate analysis showed that high hepcidin levels were protective (P = 0.02, relative risk = 0.367). Multivariate analysis confirmed high hepcidin as a protective factor (P = 0.048, 95% confidence interval: 0.055–0.984). Conclusions: High hepcidin level as a protective factor for death outcome on pediatric sepsis.
26 March 2025 in American Journal of Pediatrics
Thyroid hormones play an important role in the formation and maturation of the central nervous system. Congenital hypothyroid very rarely shows clinical symptoms in early life so that cases of delayed treatment increase. Babies with untreated congenital hypothyroidism can develop into individuals with intellectual disabilities and be accompanied by motor deficits, such as impaired gross and fine motor function and balance coordination. This study aims to proving that there is a relationship between the onset of therapy in congenital hypothyroid patients and the child's language and cognitive development. The study was conducted using a cross sectional design. This research was conducted at the Children's Polyclinic at Ngoerah Hospital and Wangaya Hospital Denpasar from Desember 2022 until August 2023, using the consecutive sampling method. Based on the sample size formula of 2 unpaired proportions, the minimum number of samples is 96. Inclusion criteria are congenital hyothyroid patients were diagnosed based on TSH levels >10 uIU/mL, currently undergoing therapy and carrying out control to monitor the success of therapy for a minimum of 6 months with age < 3 years and obtain written consent from parents by signing an informed consent form. Exclusion criteria included incomplete data and clinicaly down syndrome. This study involved 107 subjects, with 45 subjects had been therapy under 3 months old and 62 subjects had been therapy more than 3 months old. Initial characteristics of the study showed that the mean age was 13.3 (±3.64) in therapy under 3 months old compare with 16.5 (±6.32) in therapy more than 3 months old. Bivariate analysis, we found significant relationship between levothyroxine therapy on language and cognitive function (p = 0.032, PR 1.74, CI=1.156-5.594). Multivariate analysis, therapy < 3 months had a significant relationship with language and cognitive development in hypothyroid children with an adjusted OR of 3.404 (95% CI 1.330 – 8.710, P value 0.011). There is a relationship between the onset of therapy in congenital hypothyroid patients and children's language development and cognition.
29 December 2025 in Trends in Pediatrics
Diagnosing abdominal tuberculosis (TB) is challenging due to its uncommon symptoms and limited diagnostic tools, which can delay treatment and increase mortality. We present two cases of abdominal TB diagnosed using different approaches. In case 1, a 6-year-old girl with a month-long history of ascites, whose father had treatment-resistant TB, was evaluated. The tuberculin test was positive, but the Xpert MTB/RIF Ultra assay was negative. Laparoscopy revealed miliary nodules, and histopathology confirmed the presence of granulomas with Langhans giant cells. In case 2, a 1-year-old girl presented with seven months of ascites and no known TB contact. The tuberculin test was negative, but an abdominal CT scan showed hepatic TB. The in-house polymerase chain reaction (PCR) for TB targeting the IS3-like element IS987 family transposase in our laboratory was positive. Both patients were diagnosed with abdominal TB, treated with the extrapulmonary (EPTB) regimen, and showed significant improvement. Diagnosing abdominal TB is complex, requiring a thorough history and adequate examination support. This might prevent delays in treatment that potentially increase complications.